Aerie Pharmaceuticals, Inc. reiterated revenue guidance for the year 2022. The company is reiterating guidance for 2022 net product revenues of between $130 million and $140 million.
1st Jan change | Capi. | |
---|---|---|
+42.60% | 739B | |
+32.34% | 598B | |
-5.74% | 353B | |
+17.79% | 318B | |
+3.37% | 285B | |
+16.47% | 240B | |
+9.26% | 210B | |
-5.07% | 206B | |
+6.74% | 164B |